Severe hypoglycaemia and absolute risk of cause-specific mortality in individuals with type 2 diabetes: a UK primary care observational study.
Aged
Aged, 80 and over
Cardiovascular Diseases
/ mortality
Cause of Death
Diabetes Mellitus, Type 2
/ drug therapy
Female
Hospitalization
Humans
Hypoglycemia
/ epidemiology
Hypoglycemic Agents
/ therapeutic use
Insulin
/ therapeutic use
Male
Middle Aged
Neoplasms
/ mortality
Primary Health Care
Prognosis
Proportional Hazards Models
Risk Factors
Severity of Illness Index
Sulfonylurea Compounds
/ therapeutic use
United Kingdom
/ epidemiology
Absolute risk
Cardiovascular disease
Causality
Competing risk
Electronic health records
Hypoglycaemia
Mortality
Observational study
Prognosis
Type 2 diabetes
Journal
Diabetologia
ISSN: 1432-0428
Titre abrégé: Diabetologia
Pays: Germany
ID NLM: 0006777
Informations de publication
Date de publication:
10 2020
10 2020
Historique:
received:
23
03
2020
accepted:
08
06
2020
pubmed:
31
7
2020
medline:
5
10
2021
entrez:
31
7
2020
Statut:
ppublish
Résumé
Several pathophysiological mechanisms would suggest a causal link between hypoglycaemia and cardiovascular death; conversely, current knowledge would not support a causal relationship with other causes of death. To clarify the nature and the magnitude of the association between hypoglycaemia and death, we investigated the 5 year mortality risks for cardiovascular disease, cancer and other causes in individuals with type 2 diabetes admitted to hospital for a severe hypoglycaemic episode. We defined in the UK Clinical Practice Research Datalink database a prevalent cohort of adults with type 2 diabetes diagnosed between 1 January 1998 and 1 January 2011 (index date), with available linkage to the Office for National Statistics (ONS) and the Hospital Episode Statistics (HES). A hospital admission reporting hypoglycaemia as the underlying cause was identified before the index date in the HES; date and underlying cause of death were obtained from the ONS. We quantified the 5 year risk of cause-specific death in people with and without admission to hospital for severe hypoglycaemia, adjusting for potential confounders and accounting for competing risk. Of the 74,610 subjects included in the cohort, 388 (0.5%) were admitted at least once for a severe hypoglycaemic episode; subjects admitted were older, with higher HbA The results of this study indicate severe hypoglycaemia as a marker of, rather than causally linked to, an increased risk of long-term mortality. Regardless of the nature of the association, a severe hypoglycaemic episode represents a strong negative prognostic factor in patients with type 2 diabetes. Graphical abstract.
Identifiants
pubmed: 32728893
doi: 10.1007/s00125-020-05223-3
pii: 10.1007/s00125-020-05223-3
pmc: PMC7476909
doi:
Substances chimiques
Hypoglycemic Agents
0
Insulin
0
Sulfonylurea Compounds
0
Types de publication
Journal Article
Observational Study
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
2129-2139Subventions
Organisme : Department of Health
ID : NIHR300111
Pays : United Kingdom
Références
Rev Cardiovasc Med. 2011;12(3):132-5
pubmed: 22080923
JAMA Intern Med. 2015 Mar;175(3):356-62
pubmed: 25581565
BMJ. 2010 Jan 08;340:b4909
pubmed: 20061358
Diabetes Obes Metab. 2017 Oct;19(10):1371-1378
pubmed: 28295974
Diabetes Care. 2012 Feb;35(2):409-14
pubmed: 22179956
Diabetes Metab J. 2016 Jun;40(3):202-10
pubmed: 27098504
Int J Epidemiol. 2015 Jun;44(3):827-36
pubmed: 26050254
Diabetes Care. 2018 Aug;41(8):1783-1791
pubmed: 29903847
Front Endocrinol (Lausanne). 2019 Aug 06;10:536
pubmed: 31447782
Diabetes Care. 2018 Jan;41(1):104-111
pubmed: 29127240
Diabetes Metab J. 2020 Feb;44(1):125-133
pubmed: 31701690
Cardiovasc Diabetol. 2019 Aug 14;18(1):103
pubmed: 31412855
Diabetologia. 2018 Jan;61(1):58-65
pubmed: 28913543
Diabetes Care. 2018 Mar;41(3):596-603
pubmed: 29311155
Diabetes Obes Metab. 2016 Aug;18(8):783-94
pubmed: 27059700
Diabetes Care. 2012 Sep;35(9):1897-901
pubmed: 22699297
Diabetes Care. 2019 Jan;42(1):157-163
pubmed: 30455335
N Engl J Med. 2010 Oct 7;363(15):1410-8
pubmed: 20925543
Diabetes Care. 2018 Dec;41(12):2669-2701
pubmed: 30291106
Diabetes Obes Metab. 2016 Feb;18(2):152-8
pubmed: 26511332
Diabetes Care. 2016 Aug;39 Suppl 2:S205-9
pubmed: 27440834
Diabetes Care. 2019 Jan;42(1):142-147
pubmed: 30425095
Diabetes Obes Metab. 2018 Sep;20(9):2159-2168
pubmed: 29732725
Ann Intern Med. 2016 Jan 19;164(2):102-13
pubmed: 26642233
Diabetes Obes Metab. 2005 Sep;7(5):493-503
pubmed: 16050942
Lancet Diabetes Endocrinol. 2019 May;7(5):385-396
pubmed: 30926258
N Engl J Med. 2008 Jun 12;358(24):2545-59
pubmed: 18539917
Lancet Diabetes Endocrinol. 2016 Aug;4(8):677-685
pubmed: 27293218
Diabetes Care. 2012 May;35(5):1126-32
pubmed: 22432106
Diabetes Care. 2015 Feb;38(2):316-22
pubmed: 25492401
Medicine (Baltimore). 2016 Nov;95(45):e5183
pubmed: 27828844
Diabetes Obes Metab. 2016 Sep;18(9):907-15
pubmed: 27161418
J Gerontol A Biol Sci Med Sci. 2017 Aug 1;72(8):1110-1116
pubmed: 27784724
Diabetes Obes Metab. 2019 Aug;21(8):1878-1885
pubmed: 30972910
Diabetes Care. 2020 Mar;43(3):643-652
pubmed: 31882409
JAMA Intern Med. 2013 Jul 22;173(14):1300-6
pubmed: 23753199
Acta Diabetol. 2020 May;57(5):549-558
pubmed: 31754819
Eur Heart J. 2020 Jan 7;41(2):209-217
pubmed: 31504427
Eur Heart J. 2013 Oct;34(40):3137-44
pubmed: 23999452